Analysis of the IDH1 codon 132 mutation in brain tumors.
about
Adjuvant treatment of anaplastic oligodendrogliomas and oligoastrocytomasIdentification and functional characterization of isocitrate dehydrogenase 1 (IDH1) mutations in thyroid cancerCancer-associated IDH1 mutations produce 2-hydroxyglutarateIDH1 and IDH2 mutations in gliomasIdentification of a CpG island methylator phenotype that defines a distinct subgroup of gliomaRecent advances in the molecular understanding of glioblastomaTargeting histone methylation for cancer therapy: enzymes, inhibitors, biological activity and perspectivesGenetics and Epigenetics of Glioblastoma: Applications and Overall Incidence of IDH1 MutationMolecular Biology in Pediatric High-Grade Glioma: Impact on Prognosis and TreatmentMolecular characterizations of glioblastoma, targeted therapy, and clinical results to dateCancer metabolism: key players in metabolic reprogrammingCerebral neoplasms in L-2 hydroxyglutaric aciduria: 3 new cases and meta-analysis of literature dataExpanding antitumor therapeutic windows by targeting cancer-specific nicotinamide adenine dinucleotide phosphate-biogenesis pathwaysNew developments in the pathogenesis and therapeutic targeting of the IDH1 mutation in gliomaNovel therapeutic targets of tumor metabolismMolecular mechanisms of "off-on switch" of activities of human IDH1 by tumor-associated mutation R132HNovel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1The prognostic IDH1( R132 ) mutation is associated with reduced NADP+-dependent IDH activity in glioblastoma.Molecular alterations of the IDH1 gene in AML: a Children's Oncology Group and Southwest Oncology Group study.Peroxisomal localization and function of NADP+ -specific isocitrate dehydrogenases in yeastGlioblastoma multiforme: emerging treatments and stratification markers beyond new drugsMetabolic consequences of oncogenic IDH mutations2-Hydoxyglutarate: D/Riving Pathology in gLiomaSDetermination of phosphate-activated glutaminase activity and its kinetics in mouse tissues using metabolic mapping (quantitative enzyme histochemistry)Proportional upregulation of CD97 isoforms in glioblastoma and glioblastoma-derived brain tumor initiating cellsIDH1 regulates phospholipid metabolism in developing astrocytesThe global DNA methylation surrogate LINE-1 methylation is correlated with MGMT promoter methylation and is a better prognostic factor for gliomaIDH mutation impairs histone demethylation and results in a block to cell differentiationGlioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1alphaManagement of low-grade glioma.MRI findings and pathological features in early-stage glioblastoma.BRAF V600E-mutated diffuse glioma in an adult patient: a case report and review.Detection of 2-hydroxyglutarate in brain tumors by triple-refocusing MR spectroscopy at 3T in vivo.Genetic signature of adult gliomas and correlation with MRI features.IDH1/IDH2 but not TP53 mutations predict prognosis in Bulgarian glioblastoma patientsIDH mutations: genotype-phenotype correlation and prognostic impact.Invasion and proliferation kinetics in enhancing gliomas predict IDH1 mutation status.Molecular analysis of ex-vivo CD133+ GBM cells revealed a common invasive and angiogenic profile but different proliferative signatures among high grade gliomas.Rosette-forming glioneuronal tumor: a pineal region case with IDH1 and IDH2 mutation analyses and literature review of 43 cases.ATRX mRNA expression combined with IDH1/2 mutational status and Ki-67 expression refines the molecular classification of astrocytic tumors: evidence from the whole transcriptome sequencing of 169 samples samples.
P2860
Q24194645-6D8851BB-CC14-4E78-A6E2-9D087F2866E3Q24300323-505F30B6-99D5-4960-B566-3F970C0F2E1AQ24320239-56142D3A-448D-4361-80DD-0C5B62B98BC2Q24561928-1A2315BA-865B-4000-8C65-AF4CC0644ACCQ24612429-987A49F7-423B-4EC8-AFA1-C37AE4C477D1Q24632928-0F1CED7F-E205-406D-AF81-29AFA154B79DQ26744441-A78B2963-8A1F-44ED-92B1-F15E312625D1Q26767392-B4832890-9845-4ED7-86D4-63AB5FA78B63Q26785952-CA222536-D98A-4294-A70B-B3FD2875524AQ26822717-962BFAF8-35E2-41E7-A1FE-28119E3C177DQ26827663-F8319FDC-43B8-4C92-8B3D-BEC5406F7287Q26827985-F3A7DE1D-DF3C-4302-886A-C87443719856Q26861539-75372EDB-0C01-4C11-9868-407A02F6DAB4Q26863394-B4F52C8A-23AC-4890-8D1B-CFF7E08DD5FDQ27005930-6E734046-CC28-4DF1-9F71-5B106050B638Q27665370-B9C08923-B518-4052-84AF-E0FE55DEF3AFQ27687464-F23D1525-987F-4EDF-A50B-606DE4B4F33AQ27851550-32DEA028-EC93-4957-968C-68E48CA079B7Q27851561-0559377C-C09F-4622-A615-9498B605CF97Q27930352-03C489E6-30F1-4443-9AD2-D7F2BF67BDA3Q28082603-3120FAC9-007E-40A7-A3F7-5E25EF1C47ADQ28082949-9E47DAE7-AD32-4679-8884-7558CF9A8D3DQ28087807-1D49AB21-B7C7-43E4-B44B-5AC283ADCDA1Q28246788-DE400870-B3D5-4013-8E76-FF333E2D1D48Q28257733-B9F3BDF0-867A-440D-9FDB-CC91497A4871Q28591697-6B9D6F0C-2E3B-40C1-900C-E24594AFE99EQ28741768-9CD8EC61-7470-4932-A47F-BB730D7EA7B3Q29305058-965F682B-32DE-440F-84CE-E25FFB905284Q29619709-767DD9B2-0EF3-4C01-A89C-4332696E68E7Q30436353-A76F1D08-0589-4B71-9014-486122F61327Q30943758-5466E9D5-3E3F-4ACF-B0C7-D21B75D45C25Q31002780-19D72A6A-2399-4A85-AD5A-FD3A3949755CQ31117278-B6F63BAA-22BB-4F79-80B0-261D39F2E42DQ33509600-E949E8A2-6ADF-4089-A4E8-D9ACE0066797Q33597773-127A4EA4-A354-4E3E-9B61-D71FD3EBBFC3Q33615867-DA8E76CA-4480-4B4C-B139-599E896405D5Q33616627-0770CECB-71D3-41B1-8B46-43C8F3112FADQ33671442-925D8675-97A6-44C5-960E-BAEB7E69EDB3Q33703764-0328B586-66E9-4F62-9721-C8DFD426314BQ33757037-5DC4C378-A921-419B-9822-7E8E2C7F36BE
P2860
Analysis of the IDH1 codon 132 mutation in brain tumors.
description
2008 nî lūn-bûn
@nan
2008 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Analysis of the IDH1 codon 132 mutation in brain tumors.
@ast
Analysis of the IDH1 codon 132 mutation in brain tumors.
@en
Analysis of the IDH1 codon 132 mutation in brain tumors.
@nl
type
label
Analysis of the IDH1 codon 132 mutation in brain tumors.
@ast
Analysis of the IDH1 codon 132 mutation in brain tumors.
@en
Analysis of the IDH1 codon 132 mutation in brain tumors.
@nl
prefLabel
Analysis of the IDH1 codon 132 mutation in brain tumors.
@ast
Analysis of the IDH1 codon 132 mutation in brain tumors.
@en
Analysis of the IDH1 codon 132 mutation in brain tumors.
@nl
P2093
P1476
Analysis of the IDH1 codon 132 mutation in brain tumors.
@en
P2093
Andrey Korshunov
Christian Hartmann
Jochen Meyer
Jörg Balss
Wolf Mueller
P2860
P2888
P304
P356
10.1007/S00401-008-0455-2
P577
2008-11-05T00:00:00Z